Pharmaceutical companies in the United States by P/E ratio
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Edgewise Therapeutics has the lowest figure of the 19 pharmaceutical companies in the United States ranked by P/E ratio, at 4.8, followed by Alnylam Pharmaceuticals (7.4) and Bristol-Myers Squibb (13.1). Figures as of 20 Nov 2026, 19:40 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 19
- Lowest
- Edgewise Therapeutics4.8
- Median
- 39.4
- Combined market value
- SEK 38.43T
- Countries
- 1
- Not ranked
- 25no P/E ratio on file
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | P/E ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Edgewise TherapeuticsEWTX · Health Care | 4.8 | SEK 45.2B | SEK 412.57 | 2.00% down | 82% up | ||
| 2 | Alnylam PharmaceuticalsALNY · Health Care | 7.4 | SEK 201.4B | SEK 1,503.85 | 0.51% down | 66% down | ||
| 3 | Bristol-Myers SquibbBMY · Health Care | 13.1 | SEK 1.24T | SEK 605.38 | 1.47% up | 26% up | ||
| 4 | ZoetisZTS · Health Care | 13.6 | SEK 332.4B | SEK 817.98 | 0.99% down | 34% down | ||
| 5 | Regeneron PharmaceuticalsREGN · Health Care | 20.4 | SEK 977.9B | SEK 9,453.39 | 0.22% up | 22% up | ||
| 6 | United TherapeuticsUTHR · Health Care | 21.0 | SEK 242.5B | SEK 5,693.67 | 0.41% down | 18% up | ||
| 7 | Protagonist TherapeuticsPTGX · Health Care | 25.9 | SEK 81.9B | SEK 1,255.15 | 1.03% down | 45% up | ||
| 8 | Vertex PharmaceuticalsVRTX · Health Care | 33.5 | SEK 1.35T | SEK 5,323.59 | 0.01% down | 22% up | ||
| 9 | Abbott LaboratoriesABT · Health Care | 38.7 | SEK 1.84T | SEK 1,061.52 | 0.06% down | 19% down | ||
| 10 | PfizerPFE · Health Care | 39.4 | SEK 1.61T | SEK 281.89 | 0.10% up | 10% up | ||
| 11 | Johnson & JohnsonJNJ · Health Care | 41.2 | SEK 6.69T | SEK 2,778.99 | 1.73% up | 31% up | ||
| 12 | Eli LillyLLY · Health Care | 43.9 | SEK 12.32T | SEK 13,834.72 | 0.13% up | 28% up | ||
| 13 | Royalty PharmaRPRX · Health Care | 44.7 | SEK 401.7B | SEK 698.65 | 0.89% up | 74% up | ||
| 14 | Corcept TherapeuticsCORT · Health Care | 47.8 | SEK 71.2B | SEK 650.58 | 2.09% down | 16% down | ||
| 15 | AbbVieABBV · Health Care | 49.6 | SEK 5.22T | SEK 2,950.89 | 1.77% up | 20% up | ||
| 16 | Amneal PharmaceuticalsAMRX · Health Care | 53.2 | SEK 75.8B | SEK 217.46 | 0.58% down | 79% up | ||
| 17 | TG TherapeuticsTGTX · Health Care | 96.2 | SEK 99.6B | SEK 659.12 | 0.66% down | 103% up | ||
| 18 | Ligand PharmaceuticalsLGND · Health Care | 115 | SEK 58.8B | SEK 2,938.05 | 0.13% up | 44% up | ||
| 19 | Merck & CoMRK · Health Care | 136 | SEK 3.39T | SEK 1,376.33 | 1.34% up | 36% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 10.2261 SEK). 25 companies have no P/E ratio on file and are not ranked here.
Questions and answers
Which pharmaceutical companies in the United States have the lowest P/E ratio?
Edgewise Therapeutics (4.8), Alnylam Pharmaceuticals (7.4) and Bristol-Myers Squibb (13.1) have the lowest P/E ratio of the 19 pharmaceutical companies in the United States ranked here as of 20 Nov 2026, 19:40 UTC.
How many pharmaceutical companies in the United States are in this ranking?
19 are ranked by P/E ratio. 25 more have no P/E ratio on file and are left out rather than ranked at zero.
What are these pharmaceutical companies in the United States worth together?
The 19 pharmaceutical companies in the United States ranked by P/E ratio have a combined market value of SEK 38.43T as of 20 Nov 2026, 19:40 UTC.
What does ranking by P/E ratio measure?
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies in the United States by P/E ratio”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=pe-ratio
Underlying data: Yahoo Finance; SEC EDGAR.